These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 22709981
1. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community. Wicks P, Vaughan TE, Massagli MP. Health Qual Life Outcomes; 2012 Jun 18; 10():70. PubMed ID: 22709981 [Abstract] [Full Text] [Related]
5. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Neurology; 2003 Jan 14; 60(1):31-6. PubMed ID: 12525714 [Abstract] [Full Text] [Related]
8. Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23). Martínez-Ginés ML, García-Domínguez JM, Forero L, Canal N, Rebollo P, Prefasi D, Honan CA, Maurino J. Mult Scler Relat Disord; 2018 May 14; 22():115-119. PubMed ID: 29656271 [Abstract] [Full Text] [Related]
10. Comparison of patient-reported outcome measures in multiple sclerosis. Schäffler N, Schönberg P, Stephan J, Stellmann JP, Gold SM, Heesen C. Acta Neurol Scand; 2013 Aug 14; 128(2):114-21. PubMed ID: 23398571 [Abstract] [Full Text] [Related]
11. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale. Pappalardo A, Patti F. Funct Neurol; 2010 Aug 14; 25(4):223-33. PubMed ID: 21388584 [Abstract] [Full Text] [Related]
12. The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Boorgu DSSK, Venkatesh S, Lakhani CM, Walker E, Aguerre IM, Riley C, Patel CJ, De Jager PL, Xia Z. Mult Scler Relat Disord; 2022 Sep 14; 65():103994. PubMed ID: 35780727 [Abstract] [Full Text] [Related]
14. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis. Motl RW, Plummer P, Backus D, Hebert JR, Neal WN, Ng A, Lowman J, Bethoux F, Schmidt H, McBurney R, McCully KK, Cutter G. Mult Scler Relat Disord; 2024 Aug 14; 88():105715. PubMed ID: 38889558 [Abstract] [Full Text] [Related]
15. Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Twiss J, Doward LC, McKenna SP, Eckert B. Health Qual Life Outcomes; 2010 Oct 11; 8():117. PubMed ID: 20937112 [Abstract] [Full Text] [Related]
16. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. Patti F, Russo P, Pappalardo A, Macchia F, Civalleri L, Paolillo A, FAMS study group. J Neurol Sci; 2007 Jan 31; 252(2):121-9. PubMed ID: 17188301 [Abstract] [Full Text] [Related]
17. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Sharrack B, Hughes RA. Mult Scler; 1999 Aug 31; 5(4):223-33. PubMed ID: 10467380 [Abstract] [Full Text] [Related]
18. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Hawton A, Green C, Telford CJ, Wright DE, Zajicek JP. Mult Scler; 2012 Jun 31; 18(6):853-61. PubMed ID: 22108867 [Abstract] [Full Text] [Related]
19. Reliability and validity of the multiple sclerosis resiliency scale (MSRS). Hughes AJ, Patel K, Fitzgerald KC, Brown A, Gromisch ES, Mowry EM. J Neurol Sci; 2020 Nov 15; 418():116983. PubMed ID: 33002759 [Abstract] [Full Text] [Related]
20. The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis. Ottonello M, Pellicciari L, Centonze D, Foti C, Pistarini C, Albensi C, Giordano A. Disabil Rehabil; 2019 Feb 15; 41(4):465-471. PubMed ID: 29069950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]